Report Detail
Global Meningococcal Polysaccharide Vaccine Market Report, History and Forecast 2017-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application
- RnM4420645 |
- 06 April, 2022 |
- Global |
- 91 Pages |
- QYResearch |
- Pharma & Healthcare
Summary:
Meningococcal polysaccharide diphtheria conjugate vaccine is an active immunizing agent used to prevent infection by certain groups of meningococcal bacteria.
Market Insights
Due to the COVID-19 pandemic, the global Meningococcal Polysaccharide Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028.
The global main manufacturers of Meningococcal Polysaccharide Vaccine include Sanofi, Bio-Med, CanSinoBIO, Walvax Biotechnology, Chongqing Zhifei Biological, Chengdu Kanghua Biological Products, Changsheng Biotechnology and CanSinoBIO, etc. In 2021, the global six largest players have a share approximately % in terms of revenue.
The North America Meningococcal Polysaccharide Vaccine market is estimated at US$ million in 2021, while China is forecast to reach US$ million by 2028. The proportion of the China is % in 2021 and it is predicted that the share will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. As for the Europe Meningococcal Polysaccharide Vaccine landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Polysaccharide Meningtitis AC accounting for % of the Meningococcal Polysaccharide Vaccine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While 6 Months-15Year segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
Segment Scope
An intensive study of key type and application segments has been done in this segmentation section. The authors of the report have provided reliable figures including sales and revenue forecast data by type and application for the period 2017-2028. They have also studied how the segments are gaining or losing growth in various geographies and their respective countries. Thanks to this study, readers can thoroughly grasp the growth pattern and potential of different segments.
Segment by Type
Polysaccharide Meningtitis AC
Meningitis ACYW
Segment by Application
6 Months-15Year
over 3 Year
over 2 Year
over 3 Months
Regional Scope
This segment of the report offers a thorough regional study of the global Meningococcal Polysaccharide Vaccine market. Drivers and restraints for each region are broadly examined in the report. Readers will get familiar with the driving forces and challenges that are specific to the regions. The specialists have identified growth opportunities in key geographical regions and their respective countries to aid players to reinforce their presence. All the regions and their countries in the report are assessed based on the growth rate, revenue, and sales volume according to the consumption for the period 2017-2028. This geographical analysis will help readers to gain in-depth knowledge of the regional growth. The key geographical regions surveyed in this research report involve North America, Europe, Asia Pacific, Central and South America, and Middle East and Africa. The report has specifically covered major countries including United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
Key Players
This section has provided an exhaustive analysis of the strategies that the companies are focusing on to stay ahead of other players. The strategies mainly involve research and development, new product developments, and mergers and acquisitions. The researchers have also provided revenue shares of the key companies, company overview, and the latest company developments so as to help players to sustain the cutthroat competition. In this section, the report offers global revenue and sales data of manufacturers for the period 2017-2022. Following is the list of key manufacturers observed in this research study:
Sanofi
Bio-Med
CanSinoBIO
Walvax Biotechnology
Chongqing Zhifei Biological
Chengdu Kanghua Biological Products
Changsheng Biotechnology
CanSinoBIO
Frequently Asked Questions
Which application segment captured the leading share in the Meningococcal Polysaccharide Vaccine market?
How fragmented is the Meningococcal Polysaccharide Vaccine market?
Which are the key growth drivers in the Meningococcal Polysaccharide Vaccine market?
Which are the top strategies undertaken by the Meningococcal Polysaccharide Vaccine market players?
Which technological trends are likely to affect the Meningococcal Polysaccharide Vaccine market?
What is the expected Meningococcal Polysaccharide Vaccine market size by 2028?
Which companies are dominating the Meningococcal Polysaccharide Vaccine market?
Which region is projected to witness the fastest growth in the future?
What factors are restraining the Meningococcal Polysaccharide Vaccine market growth?
Which are the emerging companies in the Meningococcal Polysaccharide Vaccine market?
Table of Contents
1 Meningococcal Polysaccharide Vaccine Market Overview
- 1.1 Meningococcal Polysaccharide Vaccine Product Overview
- 1.2 Meningococcal Polysaccharide Vaccine Market Segment by Type
- 1.2.1 Polysaccharide Meningtitis AC
- 1.2.2 Meningitis ACYW
- 1.3 Global Meningococcal Polysaccharide Vaccine Market Size by Type
- 1.3.1 Global Meningococcal Polysaccharide Vaccine Market Size Overview by Type (2017-2028)
- 1.3.2 Global Meningococcal Polysaccharide Vaccine Historic Market Size Review by Type (2017-2022)
- 1.3.2.1 Global Meningococcal Polysaccharide Vaccine Sales Breakdown in Volume by Type (2017-2022)
- 1.3.2.2 Global Meningococcal Polysaccharide Vaccine Sales Breakdown in Value by Type (2017-2022)
- 1.3.2.3 Global Meningococcal Polysaccharide Vaccine Average Selling Price (ASP) by Type (2017-2022)
- 1.3.3 Global Meningococcal Polysaccharide Vaccine Forecasted Market Size by Type (2023-2028)
- 1.3.3.1 Global Meningococcal Polysaccharide Vaccine Sales Breakdown in Volume by Type (2023-2028)
- 1.3.3.2 Global Meningococcal Polysaccharide Vaccine Sales Breakdown in Value by Type (2023-2028)
- 1.3.3.3 Global Meningococcal Polysaccharide Vaccine Average Selling Price (ASP) by Type (2023-2028)
- 1.4 Key Regions Market Size Segment by Type
- 1.4.1 North America Meningococcal Polysaccharide Vaccine Sales Breakdown by Type (2017-2022)
- 1.4.2 Europe Meningococcal Polysaccharide Vaccine Sales Breakdown by Type (2017-2022)
- 1.4.3 Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Breakdown by Type (2017-2022)
- 1.4.4 Latin America Meningococcal Polysaccharide Vaccine Sales Breakdown by Type (2017-2022)
- 1.4.5 Middle East and Africa Meningococcal Polysaccharide Vaccine Sales Breakdown by Type (2017-2022)
2 Global Meningococcal Polysaccharide Vaccine Market Competition by Company
- 2.1 Global Top Players by Meningococcal Polysaccharide Vaccine Sales (2017-2022)
- 2.2 Global Top Players by Meningococcal Polysaccharide Vaccine Revenue (2017-2022)
- 2.3 Global Top Players Meningococcal Polysaccharide Vaccine Price (2017-2022)
- 2.4 Global Top Manufacturers Meningococcal Polysaccharide Vaccine Manufacturing Base Distribution, Sales Area, Product Type
- 2.5 Meningococcal Polysaccharide Vaccine Market Competitive Situation and Trends
- 2.5.1 Meningococcal Polysaccharide Vaccine Market Concentration Rate (2017-2022)
- 2.5.2 Global 5 and 10 Largest Manufacturers by Meningococcal Polysaccharide Vaccine Sales and Revenue in 2021
- 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Meningococcal Polysaccharide Vaccine as of 2021)
- 2.7 Date of Key Manufacturers Enter into Meningococcal Polysaccharide Vaccine Market
- 2.8 Key Manufacturers Meningococcal Polysaccharide Vaccine Product Offered
- 2.9 Mergers & Acquisitions, Expansion
3 Meningococcal Polysaccharide Vaccine Status and Outlook by Region
- 3.1 Global Meningococcal Polysaccharide Vaccine Market Size and CAGR by Region: 2017 VS 2021 VS 2028
- 3.2 Global Meningococcal Polysaccharide Vaccine Historic Market Size by Region
- 3.2.1 Global Meningococcal Polysaccharide Vaccine Sales in Volume by Region (2017-2022)
- 3.2.2 Global Meningococcal Polysaccharide Vaccine Sales in Value by Region (2017-2022)
- 3.2.3 Global Meningococcal Polysaccharide Vaccine Sales (Volume & Value) Price and Gross Margin (2017-2022)
- 3.3 Global Meningococcal Polysaccharide Vaccine Forecasted Market Size by Region
- 3.3.1 Global Meningococcal Polysaccharide Vaccine Sales in Volume by Region (2023-2028)
- 3.3.2 Global Meningococcal Polysaccharide Vaccine Sales in Value by Region (2023-2028)
- 3.3.3 Global Meningococcal Polysaccharide Vaccine Sales (Volume & Value), Price and Gross Margin (2023-2028)
4 Global Meningococcal Polysaccharide Vaccine by Application
- 4.1 Meningococcal Polysaccharide Vaccine Market Segment by Application
- 4.1.1 6 Months-15Year
- 4.1.2 over 3 Year
- 4.1.3 over 2 Year
- 4.1.4 over 3 Months
- 4.2 Global Meningococcal Polysaccharide Vaccine Market Size by Application
- 4.2.1 Global Meningococcal Polysaccharide Vaccine Market Size Overview by Application (2017-2028)
- 4.2.2 Global Meningococcal Polysaccharide Vaccine Historic Market Size Review by Application (2017-2022)
- 4.2.2.1 Global Meningococcal Polysaccharide Vaccine Sales Breakdown in Volume, by Application (2017-2022)
- 4.2.2.2 Global Meningococcal Polysaccharide Vaccine Sales Breakdown in Value, by Application (2017-2022)
- 4.2.2.3 Global Meningococcal Polysaccharide Vaccine Average Selling Price (ASP) by Application (2017-2022)
- 4.2.3 Global Meningococcal Polysaccharide Vaccine Forecasted Market Size by Application (2023-2028)
- 4.2.3.1 Global Meningococcal Polysaccharide Vaccine Sales Breakdown in Volume, by Application (2023-2028)
- 4.2.3.2 Global Meningococcal Polysaccharide Vaccine Sales Breakdown in Value, by Application (2023-2028)
- 4.2.3.3 Global Meningococcal Polysaccharide Vaccine Average Selling Price (ASP) by Application (2023-2028)
- 4.3 Key Regions Market Size Segment by Application
- 4.3.1 North America Meningococcal Polysaccharide Vaccine Sales Breakdown by Application (2017-2022)
- 4.3.2 Europe Meningococcal Polysaccharide Vaccine Sales Breakdown by Application (2017-2022)
- 4.3.3 Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Breakdown by Application (2017-2022)
- 4.3.4 Latin America Meningococcal Polysaccharide Vaccine Sales Breakdown by Application (2017-2022)
- 4.3.5 Middle East and Africa Meningococcal Polysaccharide Vaccine Sales Breakdown by Application (2017-2022)
5 North America Meningococcal Polysaccharide Vaccine by Country
- 5.1 North America Meningococcal Polysaccharide Vaccine Historic Market Size by Country
- 5.1.1 North America Meningococcal Polysaccharide Vaccine Sales in Volume by Country (2017-2022)
- 5.1.2 North America Meningococcal Polysaccharide Vaccine Sales in Value by Country (2017-2022)
- 5.2 North America Meningococcal Polysaccharide Vaccine Forecasted Market Size by Country
- 5.2.1 North America Meningococcal Polysaccharide Vaccine Sales in Volume by Country (2023-2028)
- 5.2.2 North America Meningococcal Polysaccharide Vaccine Sales in Value by Country (2023-2028)
6 Europe Meningococcal Polysaccharide Vaccine by Country
- 6.1 Europe Meningococcal Polysaccharide Vaccine Historic Market Size by Country
- 6.1.1 Europe Meningococcal Polysaccharide Vaccine Sales in Volume by Country (2017-2022)
- 6.1.2 Europe Meningococcal Polysaccharide Vaccine Sales in Value by Country (2017-2022)
- 6.2 Europe Meningococcal Polysaccharide Vaccine Forecasted Market Size by Country
- 6.2.1 Europe Meningococcal Polysaccharide Vaccine Sales in Volume by Country (2023-2028)
- 6.2.2 Europe Meningococcal Polysaccharide Vaccine Sales in Value by Country (2023-2028)
7 Asia-Pacific Meningococcal Polysaccharide Vaccine by Region
- 7.1 Asia-Pacific Meningococcal Polysaccharide Vaccine Historic Market Size by Region
- 7.1.1 Asia-Pacific Meningococcal Polysaccharide Vaccine Sales in Volume by Region (2017-2022)
- 7.1.2 Asia-Pacific Meningococcal Polysaccharide Vaccine Sales in Value by Region (2017-2022)
- 7.2 Asia-Pacific Meningococcal Polysaccharide Vaccine Forecasted Market Size by Region
- 7.2.1 Asia-Pacific Meningococcal Polysaccharide Vaccine Sales in Volume by Region (2023-2028)
- 7.2.2 Asia-Pacific Meningococcal Polysaccharide Vaccine Sales in Value by Region (2023-2028)
8 Latin America Meningococcal Polysaccharide Vaccine by Country
- 8.1 Latin America Meningococcal Polysaccharide Vaccine Historic Market Size by Country
- 8.1.1 Latin America Meningococcal Polysaccharide Vaccine Sales in Volume by Country (2017-2022)
- 8.1.2 Latin America Meningococcal Polysaccharide Vaccine Sales in Value by Country (2017-2022)
- 8.2 Latin America Meningococcal Polysaccharide Vaccine Forecasted Market Size by Country
- 8.2.1 Latin America Meningococcal Polysaccharide Vaccine Sales in Volume by Country (2023-2028)
- 8.2.2 Latin America Meningococcal Polysaccharide Vaccine Sales in Value by Country (2023-2028)
9 Middle East and Africa Meningococcal Polysaccharide Vaccine by Country
- 9.1 Middle East and Africa Meningococcal Polysaccharide Vaccine Historic Market Size by Country
- 9.1.1 Middle East and Africa Meningococcal Polysaccharide Vaccine Sales in Volume by Country (2017-2022)
- 9.1.2 Middle East and Africa Meningococcal Polysaccharide Vaccine Sales in Value by Country (2017-2022)
- 9.2 Middle East and Africa Meningococcal Polysaccharide Vaccine Forecasted Market Size by Country
- 9.2.1 Middle East and Africa Meningococcal Polysaccharide Vaccine Sales in Volume by Country (2023-2028)
- 9.2.2 Middle East and Africa Meningococcal Polysaccharide Vaccine Sales in Value by Country (2023-2028)
10 Company Profiles and Key Figures in Meningococcal Polysaccharide Vaccine Business
- 10.1 Sanofi
- 10.1.1 Sanofi Corporation Information
- 10.1.2 Sanofi Introduction and Business Overview
- 10.1.3 Sanofi Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
- 10.1.4 Sanofi Meningococcal Polysaccharide Vaccine Products Offered
- 10.1.5 Sanofi Recent Development
- 10.2 Bio-Med
- 10.2.1 Bio-Med Corporation Information
- 10.2.2 Bio-Med Introduction and Business Overview
- 10.2.3 Bio-Med Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
- 10.2.4 Bio-Med Meningococcal Polysaccharide Vaccine Products Offered
- 10.2.5 Bio-Med Recent Development
- 10.3 CanSinoBIO
- 10.3.1 CanSinoBIO Corporation Information
- 10.3.2 CanSinoBIO Introduction and Business Overview
- 10.3.3 CanSinoBIO Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
- 10.3.4 CanSinoBIO Meningococcal Polysaccharide Vaccine Products Offered
- 10.3.5 CanSinoBIO Recent Development
- 10.4 Walvax Biotechnology
- 10.4.1 Walvax Biotechnology Corporation Information
- 10.4.2 Walvax Biotechnology Introduction and Business Overview
- 10.4.3 Walvax Biotechnology Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
- 10.4.4 Walvax Biotechnology Meningococcal Polysaccharide Vaccine Products Offered
- 10.4.5 Walvax Biotechnology Recent Development
- 10.5 Chongqing Zhifei Biological
- 10.5.1 Chongqing Zhifei Biological Corporation Information
- 10.5.2 Chongqing Zhifei Biological Introduction and Business Overview
- 10.5.3 Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
- 10.5.4 Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Products Offered
- 10.5.5 Chongqing Zhifei Biological Recent Development
- 10.6 Chengdu Kanghua Biological Products
- 10.6.1 Chengdu Kanghua Biological Products Corporation Information
- 10.6.2 Chengdu Kanghua Biological Products Introduction and Business Overview
- 10.6.3 Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
- 10.6.4 Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Products Offered
- 10.6.5 Chengdu Kanghua Biological Products Recent Development
- 10.7 Changsheng Biotechnology
- 10.7.1 Changsheng Biotechnology Corporation Information
- 10.7.2 Changsheng Biotechnology Introduction and Business Overview
- 10.7.3 Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
- 10.7.4 Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Products Offered
- 10.7.5 Changsheng Biotechnology Recent Development
- 10.8 CanSinoBIO
- 10.8.1 CanSinoBIO Corporation Information
- 10.8.2 CanSinoBIO Introduction and Business Overview
- 10.8.3 CanSinoBIO Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
- 10.8.4 CanSinoBIO Meningococcal Polysaccharide Vaccine Products Offered
- 10.8.5 CanSinoBIO Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
- 11.1 Meningococcal Polysaccharide Vaccine Key Raw Materials
- 11.1.1 Key Raw Materials
- 11.1.2 Key Raw Materials Price
- 11.1.3 Raw Materials Key Suppliers
- 11.2 Manufacturing Cost Structure
- 11.2.1 Raw Materials
- 11.2.2 Labor Cost
- 11.2.3 Manufacturing Expenses
- 11.3 Meningococcal Polysaccharide Vaccine Industrial Chain Analysis
- 11.4 Meningococcal Polysaccharide Vaccine Market Dynamics
- 11.4.1 Meningococcal Polysaccharide Vaccine Industry Trends
- 11.4.2 Meningococcal Polysaccharide Vaccine Market Drivers
- 11.4.3 Meningococcal Polysaccharide Vaccine Market Challenges
- 11.4.4 Meningococcal Polysaccharide Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
- 12.1 Sales Channel
- 12.2 Meningococcal Polysaccharide Vaccine Distributors
- 12.3 Meningococcal Polysaccharide Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Meningococcal Polysaccharide Vaccine . Industry analysis & Market Report on Meningococcal Polysaccharide Vaccine is a syndicated market report, published as Global Meningococcal Polysaccharide Vaccine Market Report, History and Forecast 2017-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of Meningococcal Polysaccharide Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
